|
1
|
Messiou C, Moskovic E, Vanel D, Morosi C,
Benchimol R, Strauss D, Miah A, Douis H, van Houdt W and Bonvalot
S: Primary retroperitoneal soft tissue sarcoma: Imaging
appearances, pitfalls and diagnostic algorithm. Eur J Surg Oncol.
43:1191–1198. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vijay A and Ram L: Retroperitoneal
liposarcoma: A comprehensive review. Am J Clin Oncol. 38:213–219.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Paloyo SR, Ramirez AD, David-Paloyo FP and
Dofitas RB: Wide excision of a retroperitoneal liposarcoma with en
bloc ureterectomy and renal salvage by autotransplantation. Case
Rep Transplant. 2019:97251692019.PubMed/NCBI
|
|
4
|
Bagaria SP, Gabriel E and Mann GN:
Multiply recurrent retroperitoneal liposarcoma. J Surg Oncol.
117:62–68. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Molina G, Hull MA, Chen YL, DeLaney TF, De
Amorim Bernstein K, Choy E, Cote G, Harmon DC, Mullen JT and Haynes
AB: Preoperative radiation therapy combined with radical surgical
resection is associated with a lower rate of local recurrence when
treating unifocal, primary retroperitoneal liposarcoma. J Surg
Oncol. 114:814–820. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mansfield SA, Pollock RE and Grignol VP:
Surgery for abdominal well-differentiated liposarcoma. Curr Treat
Options Oncol. 19:12018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cheng W, Ren X, Zhang C, Cai J, Liu Y, Han
S and Wu A: Bioinformatic profiling identifies an immune-related
risk signature for glioblastoma. Neurology. 86:2226–2234. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lin H, Zhang Q, Li X, Wu Y, Liu Y and Hu
Y: Identification of key candidate genes and pathways in hepatitis
B virus-associated acute liver failure by bioinformatical analysis.
Medicine (Baltimore). 97:e96872018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Guo Y, Bao Y, Ma M and Yang W:
Identification of key candidate genes and pathways in colorectal
cancer by integrated bioinformatical analysis. Int J Mol Sci.
18:7222017. View Article : Google Scholar
|
|
10
|
Lee S and Howell BJ: High-content
screening: Emerging hardware and software technologies. Methods
Enzymol. 414:468–483. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Barretina J, Taylor BS, Banerji S, Ramos
AH, Lagos-Quintana M, Decarolis PL, Shah K, Socci ND, Weir BA, Ho
A, et al: Subtype-specific genomic alterations define new targets
for soft-tissue sarcoma therapy. Nat Genet. 42:715–721. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Irizarry RA, Hobbs B, Collin F,
Beazer-Barclay YD, Antonellis KJ, Scherf U and Speed TP:
Exploration, normalization, and summaries of high density
oligonucleotide array probe level data. Biostatistics. 4:249–264.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wettenhall JM and Smyth GK: limmaGUI: A
graphical user interface for linear modeling of microarray data.
Bioinformatics. 20:3705–3706. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Benjamini Y and Hochberg Y: Controlling
the false discovery rate: A practical and powerful approach to
multiple testing. J R Stat Soc B (Methodological). 57:289–300.
1995. View Article : Google Scholar
|
|
15
|
Tang S, Jing H, Huang Z, Huang T, Lin S,
Liao M and Zhou J: Identification of key candidate genes in
neuropathic pain by integrated bioinformatic analysis. J Cell
Biochem. 121:1635–1648. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Balboa-Beltrán E, Duran G, Lamas MJ,
Carracedo A and Barros F: Long survival and severe toxicity under
5-fluorouracil-based therapy in a patient with colorectal cancer
who harbors a germline codon-stop mutation in TYMS. Mayo Clin Proc.
90:1298–1303. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee SW, Chen TJ, Lin LC, Li CF, Chen LT,
Hsing CH, Hsu HP, Tsai CJ, Huang HY and Shiue YL: Overexpression of
thymidylate synthetase confers an independent prognostic indicator
in nasopharyngeal carcinoma. Exp Mol Pathol. 95:83–90. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lam SK, Mak JC, Zheng CY, Li YY, Kwong YL
and Ho JC: Downregulation of thymidylate synthase with arsenic
trioxide in lung adenocarcinoma. Int J Oncol. 44:2093–2102. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Formentini A, Henne-Bruns D and Kornmann
M: Thymidylate synthase expression and prognosis of patients with
gastrointestinal cancers receiving adjuvant chemotherapy: A review.
Langenbecks Arch Surg. 389:405–413. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lam SK, Li YY, Zheng CY and Ho JC:
Downregulation of thymidylate synthase and E2F1 by arsenic trioxide
in mesothelioma. Int J Oncol. 46:113–122. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Burdelski C, Strauss C, Tsourlakis MC,
Kluth M, Hube-Magg C, Melling N, Lebok P, Minner S, Koop C, Graefen
M, et al: Overexpression of thymidylate synthase (TYMS) is
associated with aggressive tumor features and early PSA recurrence
in prostate cancer. Oncotarget. 6:8377–8387. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Abdallah EA, Fanelli MF, Buim ME, Machado
Netto MC, Gasparini Junior JL, Souza E, Silva V, Dettino AL,
Mingues NB, Romero JV, et al: Thymidylate synthase expression in
circulating tumor cells: A new tool to predict 5-fluorouracil
resistance in metastatic colorectal cancer patients. Int J Cancer.
137:1397–1405. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ding B, Gao M, Li Z, Xu C, Fan S and He W:
Expression of TYMS in lymph node metastasis from low-grade glioma.
Oncol Lett. 10:1569–1574. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shichijo S, Azuma K, Komatsu N, Ito M,
Maeda Y, Ishihara Y and Itoh K: Two proliferation-related proteins,
TYMS and PGK1, could be new cytotoxic T lymphocyte-directed
tumor-associated antigens of HLA-A2+ colon cancer. Clin Cancer Res.
10:5828–5836. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mpindi JP, Sara H, Haapa-Paananen S,
Kilpinen S, Pisto T, Bucher E, Ojala K, Iljin K, Vainio P, Björkman
M, et al: GTI: A novel algorithm for identifying outlier gene
expression profiles from integrated microarray datasets. PLoS One.
6:e172592011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Abu Lila AS, Moriyoshi N, Fukushima M,
Huang CL, Wada H and Ishida T: Metronomic S-1 dosing and
thymidylate synthase silencing have synergistic antitumor efficacy
in a colorectal cancer xenograft model. Cancer Lett. 400:223–231.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ide H, Kikuchi E, Hasegawa M, Hattori S,
Yasumizu Y, Miyajima A and Oya M: Therapeutic enhancement of S-1
with CPT-11 through down-regulation of thymidylate synthase in
bladder cancer. Cancer Med. 2:488–495. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ligabue A, Marverti G, Liebl U and
Myllykallio H: Transcriptional activation and cell cycle block are
the keys for 5-fluorouracil induced up-regulation of human
thymidylate synthase expression. PLoS One. 7:e473182012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Maude SL, Dolai S, Delgado-Martin C,
Vincent T, Robbins A, Selvanathan A, Ryan T, Hall J, Wood AC,
Tasian SK, et al: Efficacy of JAK/STAT pathway inhibition in murine
xenograft models of early T-cell precursor (ETP) acute
lymphoblastic leukemia. Blood. 125:1759–1767. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Toh TB, Lim JJ, Hooi L, Rashid M and Chow
EK: Targeting Jak/Stat pathway as a therapeutic strategy against
SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular
carcinoma. J Hepatol. 72:104–118. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang H, Ma P, Cao Y, Zhang M, Li L, Wei J,
Tao L and Qian K: ECPIRM, a potential therapeutic agent for
cutaneous T-cell lymphoma, inhibits cell proliferation and promotes
apoptosis via a JAK/STAT pathway. Anticancer Agents Med Chem.
18:401–411. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Olbrich T, Mayor-Ruiz C, Vega-Sendino M,
Gomez C, Ortega S, Ruiz S and Fernandez-Capetillo O: A
p53-dependent response limits the viability of mammalian haploid
cells. Proc Natl Acad Sci USA. 114:9367–9372. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Peng K, Li X, Wu C, Wang Y, Yu J, Zhang J,
Gao Q, Zhang W, Zhang Q, Fan Y, et al: Derivation of haploid
trophoblast stem cells via conversion in vitro. iScience.
11:508–518. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li Y and Shuai L: A versatile genetic
tool: Haploid cells. Stem Cell Res Ther. 8:1972017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fletcher CDM, Bridge JA, Hogendoorn P and
Mertens F: World Health Organization, International Agency for
Research on Cancer. WHO classification of tumours of soft tissue
and bone. (4th). (Lyon). IARC Press. 2013.
|
|
37
|
Trojani M, Contesso G, Coindre JM, Rouesse
J, Bui NB, de Mascarel A, Goussot JF, David M, Bonichon F and
Lagarde C: Soft-tissue sarcomas of adults; study of pathological
prognostic variables and definition of a histopathological grading
system. Int J Cancer. 33:37–42. 1984. View Article : Google Scholar : PubMed/NCBI
|
